on December 10, 2007
Circulation. 2007
Published online before print December 10, 2007, doi: 10.1161/CIRCULATIONAHA.107.188209
Published online before print December 10, 2007, doi: 10.1161/CIRCULATIONAHA.107.188209
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
Accepted on ,
2007 Focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Elliott M. Antman MD, FACC, FAHA,
Related Internet Resources:
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Full Text
This article has been cited by other articles:
 |
|
 |
|
  D. H. Kim, C. Daskalakis, S. C. Silvestry, M. P. Sheth, A. N. Lee, S. Adams, S. Hohmann, S. Medvedev, and D. J. Whellan Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg., December 1, 2009; 138(6): 1377 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Domanski and E. R. Schwarz Clinical Review: Is the Perioperative Use of {beta}-Blockers Still Recommended? A Critical Review of Recent Controversies Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 258 - 268. [Abstract] [PDF]
|
|
|
|
 |
|
 J. L. Lopez-Sendon and R. F. Storey Introduction Eur. Heart J. Suppl., December 1, 2009; 11(suppl_G): G2 - G3. [Full Text] [PDF]
|
|
|
|
 |
|
 D P Chew, L T Huynh, D Liew, C Astley, A Soman, and D Brieger Potential survival gains in the treatment of myocardial infarction Heart, November 15, 2009; 95(22): 1844 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kumar and C. P. Cannon Acute Coronary Syndromes: Diagnosis and Management, Part II Mayo Clin. Proc., November 1, 2009; 84(11): 1021 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Stone, J. L. Martin, M.-J. de Boer, M. Margheri, E. Bramucci, J. C. Blankenship, D. C. Metzger, R. J. Gibbons, B. S. Lindsay, B. H. Weiner, et al. Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction Circ Cardiovasc Interv, October 1, 2009; 2(5): 366 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Nestler, A. Noheria, L. H. Haro, L. G. Stead, W. W. Decker, L. N. Scanlan-Hanson, R. J. Lennon, C.-C. Lim, D. R. Holmes Jr, C. S. Rihal, et al. Sustaining Improvement in Door-to-Balloon Time Over 4 Years: The Mayo Clinic ST-Elevation Myocardial Infarction Protocol Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 508 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Wang, G. C. Fonarow, A. F. Hernandez, L. Liang, G. Ellrodt, B. K. Nallamothu, B. R. Shah, C. P. Cannon, and E. D. Peterson The Dissociation Between Door-to-Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes Arch Intern Med, August 10, 2009; 169(15): 1411 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Lopes, L. E. Elliott, H. D. White, J. S. Hochman, F. Van de Werf, D. Ardissino, T. T. Nielsen, W. D. Weaver, P. Widimsky, P. W. Armstrong, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial Eur. Heart J., August 2, 2009; 30(16): 2019 - 2028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W.A. Verheugt Routine Angioplasty after Fibrinolysis -- How Early Should "Early" Be? N. Engl. J. Med., June 25, 2009; 360(26): 2779 - 2781. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Chan, J. L. Sun, L. K. Newby, L. K. Shaw, M. Lin, E. D. Peterson, R. M. Califf, D. F. Kong, and M. T. Roe Long-Term Mortality of Patients Undergoing Cardiac Catheterization for ST-Elevation and Non-ST-Elevation Myocardial Infarction Circulation, June 23, 2009; 119(24): 3110 - 3117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tatu-Chitoiu, M. Cinteza, M. Dorobantu, M. Udeanu, O. Manfrini, C. Pizzi, M. Vintila, D. D. Ionescu, E. Craiu, D. Burghina, et al. In-hospital case fatality rates for acute myocardial infarction in Romania Can. Med. Assoc. J., June 9, 2009; 180(12): 1207 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ganame, G. Messalli, S. Dymarkowski, F. E. Rademakers, W. Desmet, F. Van de Werf, and J. Bogaert Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction Eur. Heart J., June 2, 2009; 30(12): 1440 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Newland, V. F. Mauro, and K. S. Alexander Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents Am. J. Health Syst. Pharm., June 1, 2009; 66(11): 986 - 987. [Full Text] [PDF]
|
|
|
|
|
|
M. Busk, A. Kaltoft, S. S. Nielsen, M. Bottcher, M. Rehling, L. Thuesen, H. E. Botker, J. F. Lassen, E. H. Christiansen, L. R. Krusell, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h Eur. Heart J., June 1, 2009; 30(11): 1322 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A Nutescu, S. A Spinler, A. Wittkowsky, and W. E Dager Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings Ann. Pharmacother., June 1, 2009; 43(6): 1064 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Mehta, C. B. Granger, W. E. Boden, P. G. Steg, J.-P. Bassand, D. P. Faxon, R. Afzal, S. Chrolavicius, S. S. Jolly, P. Widimsky, et al. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes N. Engl. J. Med., May 21, 2009; 360(21): 2165 - 2175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mega, S. L. Close, S. D. Wiviott, L. Shen, R. D. Hockett, J. T. Brandt, J. R. Walker, E. M. Antman, W. L. Macias, E. Braunwald, et al. Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes Circulation, May 19, 2009; 119(19): 2553 - 2560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yip, M. Leduc, V. Teo, M. Timmons, and M. J. Schull A Novel Method to Link and Validate Routinely Collected Emergency Department Clinical Data to Measure Quality of Care American Journal of Medical Quality, May 1, 2009; 24(3): 185 - 191. [Abstract] [PDF]
|
|
|
|
|
|
E. Blasco-Colmenares, T. M. Perl, E. Guallar, W. A. Baumgartner, J. V. Conte, D. Alejo, R. Pastor-Barriuso, A. R. Sharrett, and N. Faraday Aspirin Plus Clopidogrel and Risk of Infection After Coronary Artery Bypass Surgery Arch Intern Med, April 27, 2009; 169(8): 788 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chua and A. Ignaszewski Clopidogrel in acute coronary syndromes BMJ, April 14, 2009; 338(apr14_1): b1180 - b1180. [Full Text]
|
|
|
|
 |
|
 D. J. Angiolillo Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions Diabetes Care, April 1, 2009; 32(4): 531 - 540. [Full Text] [PDF]
|
|
|
|
|
|
A. Sourgounis, J. Lipiecki, T. S. Lo, and M. Hamon Coronary Stents and Chronic Anticoagulation Circulation, March 31, 2009; 119(12): 1682 - 1688. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Antman and E. D. Peterson Tools for Guiding Clinical Practice From the American Heart Association and the American College of Cardiology: What Are They and How Should Clinicians Use Them? Circulation, March 10, 2009; 119(9): 1180 - 1185. [Full Text] [PDF]
|
|
|
|
|
|
P. W. Armstrong, C. M. Westerhout, and R. C. Welsh Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1293 - 1303. [Full Text] [PDF]
|
|
|
|
|
|
S. Cheng, D. A. Morrow, S. Sloan, E. M. Antman, and M. S. Sabatine Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1195 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Eikelboom and J. I. Weitz Anticoagulation for ST-Segment Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1186 - 1188. [Full Text] [PDF]
|
|
|
|
|
|
C J Terkelsen, E H Christiansen, J T Sorensen, S D Kristensen, J F Lassen, L Thuesen, H R Andersen, W Vach, and T T Nielsen Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time Heart, March 1, 2009; 95(5): 362 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ndrepepa, A. Kastrati, J. Mehilli, D. Antoniucci, and A. Schomig Mechanical Reperfusion and Long-term Mortality in Patients With Acute Myocardial Infarction Presenting 12 to 48 Hours From Onset of Symptoms JAMA, February 4, 2009; 301(5): 487 - 488. [Full Text] [PDF]
|
|
|
|
|
|
M. Cohen Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care Mayo Clin. Proc., February 1, 2009; 84(2): 149 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Terpening An Appraisal of Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Prevention of Cardiovascular Events J Am Board Fam Med, January 1, 2009; 22(1): 51 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr Secondary Prevention of Atherothrombotic Events After Ischemic Stroke Mayo Clin. Proc., January 1, 2009; 84(1): 43 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Masoudi, R. O. Bonow, R. G. Brindis, C. P. Cannon, J. DeBuhr, S. Fitzgerald, P. A. Heidenreich, K. K.L. Ho, H. M. Krumholz, C. Leber, et al. ACC/AHA 2008 Statement on Performance Measurement and Reperfusion Therapy: A Report of the ACC/AHA Task Force on Performance Measures (Work Group to Address the Challenges of Performance Measurement and Reperfusion Therapy) J. Am. Coll. Cardiol., December 9, 2008; 52(24): 2100 - 2112. [Full Text] [PDF]
|
|
|
|
|
|
WRITING COMMITTEE MEMBERS, F. A. Masoudi, R. O. Bonow, R. G. Brindis, C. P. Cannon, J. DeBuhr, S. Fitzgerald, P. A. Heidenreich, K. K.L. Ho, H. M. Krumholz, et al. ACC/AHA 2008 Statement on Performance Measurement and Reperfusion Therapy: A Report of the ACC/AHA Task Force on Performance Measures (Work Group to Address the Challenges of Performance Measurement and Reperfusion Therapy) Circulation, December 9, 2008; 118(24): 2649 - 2661. [Full Text] [PDF]
|
|
|
|
|
|
N. Danchin, E. Durand, and D. Blanchard Pre-hospital thrombolysis in perspective Eur. Heart J., December 1, 2008; 29(23): 2835 - 2842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dudek, T. Rakowski, A. Dziewierz, and P. Kleczynski PCI after lytic therapy: when and how? Eur. Heart J. Suppl., December 1, 2008; 10(suppl_J): J15 - J20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ceriello Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 260 - 268. [Abstract] [PDF]
|
|
|
|
|
|
M. Zimarino and R. De Caterina Long-term treatment strategies for atherothrombotic disease: do platelets define the course? Eur. Heart J. Suppl., November 1, 2008; 10(suppl_I): I8 - I13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sanz-Ruiz and F. Fernandez-Aviles European perspective on the use of antiplatelet agents in atherothrombotic disease Eur. Heart J. Suppl., November 1, 2008; 10(suppl_I): I14 - I18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Vlaar, T. Svilaas, K. Damman, B. J.G.L. de Smet, J. G.P. Tijssen, H. L. Hillege, and F. Zijlstra Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review Circulation, October 28, 2008; 118(18): 1828 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Ting, H. M. Krumholz, E. H. Bradley, D. C. Cone, J. P. Curtis, B. J. Drew, J. M. Field, W. J. French, W. B. Gibler, D. C. Goff, et al. Implementation and Integration of Prehospital ECGs Into Systems of Care for Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology Circulation, September 2, 2008; 118(10): 1066 - 1079. [Full Text] [PDF]
|
|
|
|
 |
|
 C. W Good and P. B Berger Review: reduction in resting heart rate after taking {beta}-blockers or calcium-channel blockers reduce mortality and morbidity after MI Evid. Based Med., August 1, 2008; 13(4): 112 - 112. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Antman and D. A. Morrow Biomarker Release After Percutaneous Coronary Intervention: A Message From the Heart Circ Cardiovasc Interv, August 1, 2008; 1(1): 3 - 6. [Full Text] [PDF]
|
|
|
|
|
|
A. W.J. van 't Hof The challenge of reducing time to reperfusion in patients with acute ST elevation myocardial infarction Eur. Heart J., August 1, 2008; 29(15): 1793 - 1794. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part I: Primary Percutaneous Coronary Intervention Circulation, July 29, 2008; 118(5): 538 - 551. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions Circulation, July 29, 2008; 118(5): 552 - 566. [Full Text] [PDF]
|
|
|
|
|
|
E. R. Bates and B. K. Nallamothu Commentary: The Role of Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction Circulation, July 29, 2008; 118(5): 567 - 573. [Full Text] [PDF]
|
|
|
|
|
|
J. Sullivan and N. Amarshi Dual antiplatelet therapy with clopidogrel and aspirin Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1134 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mosca Aspirin Chemoprevention: One Size Does Not Fit All Circulation, June 3, 2008; 117(22): 2844 - 2846. [Full Text] [PDF]
|
|
|
|
|
|
A J. Hermosillo and S. A Spinler Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous? Ann. Pharmacother., June 1, 2008; 42(6): 790 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Morrow Antithrombotic Therapy to Support Primary PCI N. Engl. J. Med., May 22, 2008; 358(21): 2280 - 2282. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. London Quo Vadis, Perioperative Beta Blockade? Are You "POISE'd" on the Brink? Anesth. Analg., April 1, 2008; 106(4): 1025 - 1030. [Full Text] [PDF]
|
|